Is SCHD a Good ETF to Buy?
With around $65.7 billion in net assets, Schwab’s US Dividend…
Sell
29
BAYZF Quote, Financials, Valuation and Earnings
Last price:
$20.78
Seasonality move
:
0.46%
Day range:
$20.78 - $21.11
52-week range:
$19.50 - $39.23
Dividend yield:
0.57%
P/E ratio:
--
P/S ratio:
0.40x
P/B ratio:
0.60x
Volume:
551
Avg. volume:
19.1K
1-year change:
-46.61%
Market cap:
$20.4B
Revenue:
$51.6B
EPS (TTM):
-$1.03
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Bayer AG has -- downside to fair value with a price target of -- per share.
BAYZF vs. S&P 500
-
Over the past 5 trading days, Bayer AG has overperformed the S&P 500 by 4.52% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Bayer AG does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Bayer AG revenues have been falling on a year-over-year basis for 3 quarters in a row. In the most recent quarter Bayer AG reported revenues of $11B.
Earnings Growth
-
Bayer AG earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Bayer AG reported earnings per share of -$4.69.
Enterprise value:
13.5B
EV / Invested capital:
--
Price / LTM sales:
0.40x
EV / EBIT:
6.81x
EV / Revenue:
0.27x
PEG ratio (5yr expected):
--
EV / Free cash flow:
2.34x
Price / Operating cash flow:
3.54x
Enterprise value / EBITDA:
1.33x
Gross Profit (TTM):
$28.9B
Return On Assets:
-0.81%
Net Income Margin (TTM):
-2.02%
Return On Equity:
-2.79%
Return On Invested Capital:
-2.23%
Operating Margin:
-38.34%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $54.2B | $51B | $50.7B | $11.3B | $11B | |
| Gross Profit | $33.8B | $29.6B | $28.9B | $6B | $5.4B | |
| Operating Income | $12.5B | $30M | $10.1B | -$3.9B | -$4.2B | |
| EBITDA | $13B | $11.6B | $10.1B | $1.6B | $1.2B | |
| Diluted EPS | $5.35 | -$4.15 | -$1.03 | -$5.07 | -$4.69 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $46.2B | $37.1B | $37.8B | $39.7B | $37B | |
| Total Assets | $140.3B | $135.2B | $128.8B | $124.1B | $119.4B | |
| Current Liabilities | $42B | $33.3B | $32.6B | $35B | $28B | |
| Total Liabilities | $103.4B | $98.9B | $88B | $88.6B | $85.2B | |
| Total Equity | $37B | $36.3B | $40.8B | $35.5B | $34.3B | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $7.7B | $2.9B | $8.7B | $2.8B | $2.3B | |
| Cash From Investing | -$3.6B | $354.6M | -$2.6B | -$151.1M | $4.1B | |
| Cash From Financing | -$4.2B | -$424.6M | -$8.2B | -$177.4M | -$5.6B | |
| Free Cash Flow | $4.7B | -$498.8M | $5.8B | $2.1B | $1.6B | |
BAYZF
Sector
Market Cap
$20.4B
$48.9M
Price % of 52-Week High
52.97%
49.34%
Dividend Yield
0.57%
0%
Shareholder Yield
--
-0.74%
1-Year Price Total Return
-46.61%
-30.56%
Beta (5-Year)
0.940
0.754
Dividend yield:
0.57%
Annualized payout:
$2.63
Payout ratio:
-12.82%
Growth streak:
1 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$19.99
200-day SMA
Sell
Level
$27.93
Bollinger Bands (100)
Sell
Level
21.48 - 31.52
Chaikin Money Flow
Buy
Level
9.9M
20-day SMA
Buy
Level
$20.22
Relative Strength Index (RSI14)
Buy
Level
51.31
ADX Line
Buy
Level
16.01
Williams %R
Neutral
Level
-20.4969
50-day SMA
Sell
Level
$22.04
MACD (12, 26)
Sell
Level
-0.51
25-day Aroon Oscillator
Sell
Level
-32
On Balance Volume
Neutral
Level
80.1M
Financial Scores
--
Altman Z-Score
(Annual)
Level (--)
Sell
CA Score
(Annual)
Level (-1.2268)
Buy
Beneish M-Score
(Annual)
Level (-2.8916)
--
Momentum Score
Level (--)
Buy
Ohlson Score
Level (-1.4048)
Buy
Piotroski F Score
(Annual)
Level (4)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs as well as vitamins and other consumer healthcare products. The firm has a crop science business that includes seeds, pesticides, herbicides, and fungicides, which was expanded through the acquisition of Monsanto.
Stock Forecast FAQ
In the current month, BAYZF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The BAYZF average analyst price target in the past 3 months is --.
-
Where Will Bayer AG Stock Be In 1 Year?
According to analysts, the consensus estimate is that Bayer AG share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Bayer AG?
Analysts are divided on their view about Bayer AG share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Bayer AG is a Sell and believe this share price will rise from its current level to --.
-
What Is Bayer AG's Price Target?
The price target for Bayer AG over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is BAYZF A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Bayer AG is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of BAYZF?
You can purchase shares of Bayer AG via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Bayer AG shares.
-
What Is The Bayer AG Share Price Today?
Bayer AG was last trading at $20.78 per share. This represents the most recent stock quote for Bayer AG. Yesterday, Bayer AG closed at $20.78 per share.
-
How To Buy Bayer AG Stock Online?
In order to purchase Bayer AG stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is NAIL a Good ETF to Buy?
If you’re thinking about buying the NAIL ETF, this article…
3 High Dividend Dow Jones Stocks
Thanks to surging stock prices over the past two years,…
Stock Ideas
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 40x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 125x
Sell
43
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
50
NARI alert for Jan 8
Inari Medical [NARI] is up 22.25% over the past day.
Sell
38
UNF alert for Jan 8
UniFirst [UNF] is up 20.59% over the past day.
Sell
31
APOG alert for Jan 8
Apogee Enterprises [APOG] is down 19.13% over the past day.
